Safety of Rituximab in the Routine Treatment of Rheumatoid Arthritis in Italy in Patients Refractory to Anti-TNFa Drugs: Results from the Observational Retrospective-Prospective RUBINO Study. Reumatismo 2014, 66 (3), 224-232. https://doi.org/10.4081/reumatismo.2014.748.